We are live on
!
Find out more
PSC
Prentiss Smith & Co Portfolio holdings
AUM
$182M
Turnover
8.7%
1-Year Est. Return
26.44%
This Fund
S&P 500
This Quarter
Est. Return
+7.4%
1 Year Est. Return
+26.44%
3 Year Est. Return
+63.89%
5 Year Est. Return
+57.29%
10 Year Est. Return
+270.92%
AUM
$173M
AUM Growth
-$17.9M
(-9.3%)
Cap. Flow
-$30.2M
Cap. Flow
% of AUM
-17.43%
Top 10 Holdings %
Top 10 Hldgs %
55.08%
Holding
288
New
38
Increased
28
Reduced
38
Closed
40
Avg Time Held
2.2
years
Top 10 Avg Time Held
1.9
years
Top 20 Avg Time Held
1.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$4.21M |
| 2 |
CERN
Cerner Corp
CERN
|
+$1.19M |
| 3 |
UMPQ
Umpqua Holdings Corp
UMPQ
|
+$656K |
| 4 |
Danaher
DHR
|
+$524K |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$443K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$8.2M |
| 2 |
United Parcel Service
UPS
|
+$6.58M |
| 3 |
F5
FFIV
|
+$6.21M |
| 4 |
First Solar
FSLR
|
+$3.71M |
| 5 |
ORBK
Orbotech Ltd
ORBK
|
+$2.58M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 32.47% |
| 2 | Technology | 20.82% |
| 3 | Communication Services | 13.22% |
| 4 | Financials | 11.36% |
| 5 | Industrials | 8.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
126
The Kraft Heinz Company
KHC
$27.9B
| $39K | 0.02% |
506
| – | – |
2015 Q4
7 quarters
|
|
127
Nuveen New York Quality Municipal Income Fund
NAN
$331M
| $39K | 0.02% |
+2,757
| New | +$39.4K |
2017 Q3
0 quarters
|
|
128
State Street
STT
$45.2B
| $39K | 0.02% |
412
| – | – |
2016 Q4
3 quarters
|
|
129
Comcast
CMCSA
$77.4B
| $38K | 0.02% |
1,000
| – | – |
2015 Q4
7 quarters
|
|
130
Tractor Supply
TSCO
$17.4B
| $38K | 0.02% |
3,000
| – | – |
2013 Q2
17 quarters
|
|
131
iShares Select Dividend ETF
DVY
$23.2B
| $36K | 0.02% |
382
| – | – |
2014 Q4
11 quarters
|
|
132
Ford
F
$49.6B
| $36K | 0.02% |
3,000
| – | – |
2013 Q2
17 quarters
|
|
133
Novo Nordisk
NVO
$171B
| $35K | 0.02% |
1,460
| – | – |
2014 Q4
11 quarters
|
|
134
W.P. Carey
WPC
$14.8B
| $34K | 0.02% |
511
| – | – |
2013 Q2
17 quarters
|
|
135
Greif Class B
GEF.B
$4.17B
| $32K | 0.02% |
500
| – | – |
2017 Q1
2 quarters
|
|
136
Baxter International
BAX
$13.1B
| $31K | 0.02% |
500
| – | – |
2016 Q1
6 quarters
|
|
137
Expeditors International
EXPD
$25.4B
| $31K | 0.02% |
515
| – | – |
2017 Q2
1 quarter
|
|
138
Vanguard FTSE Emerging Markets ETF
VWO
$122B
| $31K | 0.02% |
+720
| New | +$31.2K |
2017 Q3
0 quarters
|
|
139
C.H. Robinson
CHRW
$16.2B
| $30K | 0.02% |
390
| – | – |
2017 Q2
1 quarter
|
|
140
Labcorp
LH
$25.7B
| $30K | 0.02% |
233
| – | – |
2017 Q2
1 quarter
|
|
141
Travelers Companies
TRV
$81B
| $30K | 0.02% |
+248
| New | +$31K |
2017 Q3
0 quarters
|
|
|
VAR
142
DELISTED
Varian Medical Systems, Inc.
VAR
| $30K | 0.02% |
300
| – | – |
2017 Q2
1 quarter
|
|
143
Ameren
AEE
$29.4B
| $29K | 0.02% |
500
| – | – |
2013 Q2
17 quarters
|
|
144
eBay
EBAY
$53.5B
| $29K | 0.02% |
757
+190
| +34% | +$6.91K |
2016 Q4
3 quarters
|
|
|
POT
145
DELISTED
Potash Corp Of Saskatchewan
POT
| $29K | 0.02% |
1,533
| – | – |
2013 Q2
17 quarters
|
|
146
Amgen
AMGN
$234B
| $28K | 0.02% |
150
| – | – |
2013 Q2
17 quarters
|
|
147
Cognizant
CTSH
$29.5B
| $28K | 0.02% |
390
| – | – |
2017 Q2
1 quarter
|
|
148
OneMain Financial
OMF
$6.44B
| $28K | 0.02% |
1,000
| – | – |
2017 Q2
1 quarter
|
|
149
Sysco
SYY
$40.3B
| $27K | 0.02% |
500
| – | – |
2017 Q1
2 quarters
|
|
150
Flagstar Bank National Association
FLG
$4.56B
| $26K | 0.02% |
667
| – | – |
2017 Q1
2 quarters
|
|
Similar funds
LAM
MPW
FNBOH
CAM
PW
DRC
MW
EWA
Prentiss Smith & Co's Q3 2017 Portfolio in Review
As of Q3 2017, Prentiss Smith & Co held 288 positions worth $173M, down 9.3% from $191M the previous quarter. Its ten largest holdings account for 55% of the portfolio.
Prentiss Smith & Co withdrew a net $30.2M in Q3 2017, closing 40 positions and reducing 38 holdings. Its most notable exit was F5, an estimated $6.21M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 26% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Prentiss Smith & Co opened a new position in Regeneron Pharmaceuticals worth $416K.
- Prentiss Smith & Co's largest Q3 2017 buy was Regeneron Pharmaceuticals: 931 shares worth $416K.
- Prentiss Smith & Co added most to Oracle in Q3 2017, an estimated $4.21M increase.
- Prentiss Smith & Co's biggest Q3 2017 reduction was Verizon, cutting an estimated $8.2M.
- Prentiss Smith & Co fully exited F5 in Q3 2017, selling an estimated $6.21M.
- Prentiss Smith & Co's ten largest holdings make up 55% of its $173M portfolio in Q3 2017.
- Prentiss Smith & Co opened 38 new positions and closed 40 in Q3 2017.
- Prentiss Smith & Co's portfolio value fell 9.3% quarter-over-quarter to $173M.
Based on Prentiss Smith & Co's 13F filing for Q3 2017, filed 23 Oct 2017.